Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Bromo-PEG8-Boc | 1623792-00-6 | 99.86% | C23H45BrO10 | 500 MG
SDP

Catalog No. 5000355318
Encompass_Preferred

Bromo-PEG8-Boc is a PEG-based PROTAC linker essential for the synthesis of Proteolysis-Targeting Chimeras (PROTACs). PROTACs are designed to contain two distinct ligands, one for an E3 ubiquitin ligase and another for a target protein, connected by a linker. This mechanism allows PROTACs to exploit the intracellular ubiquitin-proteasome system, enabling the selective degradation of specific target proteins.

  • PEG-based PROTAC linker
  • Used in the synthesis of PROTACs
  • Exploits the intracellular ubiquitin-proteasome system
  • Enables selective degradation of target proteins
  • Applicable in cancer research
  • Supports targeted therapy

Catalog No. 50-003-55318 Supplier Medchemexpress LLC Supplier No. HY141368500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bromo-PEG8-Boc is a PEG-based PROTAC linker essential for the synthesis of Proteolysis-Targeting Chimeras (PROTACs). PROTACs are designed to contain two distinct ligands, one for an E3 ubiquitin ligase and another for a target protein, connected by a linker. This mechanism allows PROTACs to exploit the intracellular ubiquitin-proteasome system, enabling the selective degradation of specific target proteins.

  • PEG-based PROTAC linker
  • Used in the synthesis of PROTACs
  • Exploits the intracellular ubiquitin-proteasome system
  • Enables selective degradation of target proteins
  • Applicable in cancer research
  • Supports targeted therapy

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.